- Q1 2024 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptMay 14, 2024$2.84 (+11.81%)Earnings
- Q4 2023 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptMar 19, 2024$2.35 (-6.37%)Earnings
- Cyclacel Pharmaceuticals Inc Extraordinary Shareholders Meeting TranscriptDec 08, 2023
- Q3 2023 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptNov 13, 2023$7.81 (-3.79%)Earnings
- Q2 2023 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptAug 09, 2023$8.28 (-5.62%)Earnings
- Q1 2023 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptMay 11, 2023$8.36 (-1.76%)Earnings
- Q4 2022 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptMar 06, 2023$11.23 (-2.79%)Earnings
- Q3 2022 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2022$17.7 (-3.28%)Earnings
- Cyclacel Pharmaceuticals Inc Research & Development Day TranscriptOct 31, 2022
- Q2 2022 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptAug 10, 2022$19.95 (+1.92%)Earnings
- Q1 2022 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptMay 11, 2022$19.8 (-11.41%)Earnings
- Q4 2021 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptMar 28, 2022$47.25 (-1.25%)Earnings
- Q3 2021 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptNov 10, 2021$76.5 (+2.31%)Earnings
- Cyclacel Pharmaceuticals Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 21, 2021
- Q2 2021 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptAug 11, 2021$78.3 (-0.95%)Earnings
- Cyclacel Pharmaceuticals Inc at Ladenburg Thalmann Virtual Healthcare Conference TranscriptJul 14, 2021
- Q1 2021 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptMay 12, 2021$95.55 (-5.63%)Earnings
- Q4 2020 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptFeb 25, 2021$105 (-5.53%)Earnings
- Q3 2020 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptNov 11, 2020$52.65 (+3.85%)Earnings
- Q2 2020 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptAug 12, 2020$68.4 (-2.15%)Earnings
- Cyclacel Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 25, 2020
- Q1 2020 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptMay 12, 2020$61.95 (-0.96%)Earnings
- Q4 2019 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptFeb 26, 2020$183.74 (-8.62%)Earnings
- Q3 2019 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptNov 13, 2019$115.39 (-1.38%)Earnings
- Q2 2019 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptAug 13, 2019$133.5 (-11.62%)Earnings
- Q1 2019 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptMay 14, 2019$207.3 (-0.58%)Earnings
- Q4 2018 Cyclacel Pharmaceuticals Inc Earnings Call TranscriptMar 27, 2019$270 (-2.20%)Earnings
Cyclacel Pharmaceuticals Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
All right, I want to thank everyone for joining us. I'm Kevin DeGeeter with Oppenheimer. The next presenting Company is Cyclacel. Joining us are the Company's CEO, Spiro Rombotis; and Company's CFO, Paul McBarron. And we're going to structure this primarily as a Q&A format. But maybe before we jump in, Spiro or Paul, maybe you can give us the 90-second overview of Cyclacel and the Company's two lead programs.
Thank you, Kevin. And thank you, the Oppenheimer team for inviting us to share our thoughts at this year's conference. As many of you who have been following the Company know, Cyclacel is an oncology-focused company. We have two drugs in development that are now in mid-stage development: fadra, long name is fadraciclib, a CDK2/9 inhibitor; and 140 or CYC140, our PLK1 inhibitor.
We recently started enrolling in the Phase 1/2 study for fadra, which actually if successful, will lead to a registration enabling outcome. This is in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)